|
09.12.2013 18:00:00
|
IMPLANET: 2014 Financial Calendar
Regulatory News:
IMPLANET (Paris:IMPL) (Euronext: IMPL, FR0010458729), a medical technology company specializing in vertebral and knee-surgery implants, announced today its schedule for the publication of financial information for 2014.
| Event | Dates* | |||
| 2013 Full-Year Sales | January 28, 2014 | |||
| 2013 Full-Year Results | March 18, 2014 | |||
| 2014 First-Quarter Sales |
April 28, 2014 |
|||
| Annual General Meeting | June 17, 2014 | |||
| 2014 First-Half Sales | July 28, 2014 | |||
| 2014 First-Half Results | September 15, 2014 | |||
| 2014 Third-Quarter Sales | October 27, 2014 |
Note (*): Press releases are published after market closes. Subject to modification.
About IMPLANET
Founded in 2007 and based near Bordeaux,
IMPLANET is a medical technology company that manufactures high-quality
implants for orthopedic surgery. Its flagship product, the JAZZ
latest-generation implant, aims to improve the treatment of spinal
pathologies requiring vertebral fusion surgery. IMPLANET’s proven
orthopedic platform, based on perfectly controlling the traceability of
its products, gives the Company the proven ability to enhance this
innovation. Protected by four families of international patents, JAZZ
has obtained 510(k) regulatory approval from the Food and Drug
Administration (FDA) in the United States and the CE mark. IMPLANET
employs 33 staff and recorded 2012 sales of €6.6 million.
For further information, please visit www.implanet.com
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IMPLANET SAmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu IMPLANET SAmehr Analysen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.